QuidelOrtho Corporation Common Stock (QDEL) Stock Price

QDELStock

$15.05−48.06%52W

Market Cap$1.03B

P/E—

PEG Ratio2.06

Div yield—

Beta0.76

QDEL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-51.27%

Price vs S&P 500 (4W)-16.13%

PEG Ratio2.06

VGM Score49.24

P/CF (Annual)9.84x

Book Value / Share (Quarterly)$27.19

P/TBV (Annual)11.89x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-5.80%

Cash Flow / Share (Quarterly)$-2.34

Price vs S&P 500 (YTD)-61.22%

Gross Margin (TTM)44.96%

Net Profit Margin (TTM)-45.57%

EPS (TTM)$-17.82

10-Day Avg Trading Volume1.53M

EPS Excl Extra (TTM)$-17.82

Revenue Growth (5Y)10.44%

EPS (Annual)$-16.69

ROI (Annual)-24.76%

Gross Margin (Annual)46.67%

Net Profit Margin (5Y Avg)-11.45%

Cash / Share (Quarterly)$2.06

Revenue Growth QoQ (YoY)-10.54%

ROA (Last FY)-19.62%

Revenue Growth TTM (YoY)-3.89%

EBITD / Share (TTM)$-11.78

ROE (5Y Avg)-16.05%

Operating Margin (TTM)-37.21%

Cash Flow / Share (Annual)$-1.22

P/B Ratio0.56x

P/B Ratio (Quarterly)0.56x

Net Income / Employee (Annual)$-174,100

EV / Revenue (TTM)1.35x

Net Interest Coverage (TTM)-5.28x

ROA (TTM)-20.65%

EV / EBITDA (TTM)121.03x

EPS Incl Extra (Annual)$-16.69

Current Ratio (Annual)1.50x

Quick Ratio (Quarterly)0.70x

3-Month Avg Trading Volume2.01M

52-Week Price Return-48.06%

EV / Free Cash Flow (Annual)10.05x

Revenue / Employee (TTM)$408,800

Tangible BV / Share (Quarterly)$1.95

P/S Ratio (Annual)0.38x

Asset Turnover (Annual)0.47x

52-Week High$35.58

Operating Margin (5Y Avg)-4.25%

EPS Excl Extra (Annual)$-16.69

CapEx CAGR (5Y)23.73%

Tangible BV CAGR (5Y)-9.58%

26-Week Price Return-40.02%

Quick Ratio (Annual)0.84x

13-Week Price Return16.95%

Total Debt / Equity (Annual)1.38x

Current Ratio (Quarterly)1.43x

Enterprise Value$3.58B

Revenue / Share Growth (5Y)1.11%

Asset Turnover (TTM)0.45x

Book Value / Share Growth (5Y)-2.13%

Revenue / Employee (Annual)$420,000

Inventory Turnover (Annual)2.62x

Pretax Margin (Annual)-40.57%

Cash / Share (Annual)$2.50

3-Month Return Std Dev106.59%

Gross Margin (5Y Avg)55.37%

Net Income / Employee (TTM)$-186,300

EBITDA Interim CAGR (5Y)-42.42%

ROE (Last FY)-58.93%

Net Interest Coverage (Annual)-5.32x

EPS Basic Excl Extra (Annual)$-16.69

P/FCF (TTM)10.78x

Receivables Turnover (TTM)7.49x

EV / Free Cash Flow (TTM)27.81x

Total Debt / Equity (Quarterly)1.45x

EPS Incl Extra (TTM)$-17.82

Receivables Turnover (Annual)7.12x

ROI (TTM)-25.22%

P/S Ratio (TTM)0.39x

Pretax Margin (5Y Avg)-8.52%

Revenue / Share (Annual)$40.27

Tangible BV / Share (Annual)$3.70

Forward P/E7.57x

Price vs S&P 500 (52W)-66.38%

Year-to-Date Return-49.26%

5-Day Price Return7.89%

EPS Normalized (Annual)$-16.69

ROA (5Y Avg)-3.30%

Net Profit Margin (Annual)-41.45%

Month-to-Date Return-13.60%

Cash Flow / Share (TTM)$7.04

EBITD / Share (Annual)$-10.84

Operating Margin (Annual)-33.85%

LT Debt / Equity (Annual)1.29x

P/CF (TTM)156.79x

ROI (5Y Avg)-3.74%

LT Debt / Equity (Quarterly)1.33x

EPS Basic Excl Extra (TTM)$-17.82

P/TBV (Quarterly)14.74x

P/B Ratio (Annual)1.04x

Inventory Turnover (TTM)2.49x

Pretax Margin (TTM)-44.35%

Book Value / Share (Annual)$28.28

Price vs S&P 500 (13W)14.16%

Beta0.76x

P/FCF (Annual)14.60x

Revenue / Share (TTM)$38.96

ROE (TTM)-56.31%

52-Week Low$9.92

vGradeC

gGradeC

mGradeC

vgmGradeC

QDEL Earnings Surprise History

Q2 250.12est. 0.01

Q3 250.80est. 0.47

Q4 250.46est. 0.42

Q1 26-0.04est. 0.36

Q2 260.13est. -0.05

QDEL Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.69

2.50

2.38

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
NEOGNeogen Corp	C	C	B	$11.64
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
TRIBTrinity Biotech plc	B	D	F	$9.71
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About QuidelOrtho Corporation Common Stock

QuidelOrtho Corp develops and manufactures rapid diagnostic testing solutions, including immunoassay, molecular testing, clinical chemistry, and transfusion medicine products. The company operates globally across North America, Europe, the Middle East and Africa, China, and other markets, with North America generating the majority of its revenue.